Effects of resveratrol and trans-3,5,4′-trimethoxystilbene on glutamate-induced cytotoxicity, heme oxygenase-1, and sirtuin 1 in HT22 neuronal cells

Biomolecules and Therapeutics

Volumn 20, Issue 3, 2012, Pages 306-312

  Kim, Dae Won ^a   Kim, Young Mi ^a   Kang, Sung Don ^a   Han, Young Min ^b   Pae, Hyun Ock ^a  

^a Wonkwang University School of Medicine   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

Author keywords

Heme oxygenase 1; Neuroprotection; Oxidative stress; Resveratrol; Sirtuin 1; Trans 3,5,4 trimethoxystilbene

Indexed keywords

HEME OXYGENASE 1; RESVERATROL; SIRTUIN 1;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION;

EID: 84862703541     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2012.20.3.306     Document Type: Article

References (49)

1. Albani, D., Polito, L., Batelli, S., De Mauro, S., Fracasso, C., Martelli, G., Colombo, L., Manzoni, C., Salmona, M., Caccia, S., Negro, A. and Forloni, G. (2009) The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide. J. Neurochem. 110, 1445-1456.
2. Albani, D., Polito, L., Signorini, A. and Forloni, G. (2010) Neuroprotective properties of resveratrol in different neurodegenerative disorders. Biofactors 36, 370-376.
3. Alex, D., Leong, E. C., Zhang, Z. J., Yan, G. T., Cheng, S. H., Leong, C. W., Li, Z. H., Lam, K. H., Chan, S. W. and Lee, S. M. (2010) Resveratrol derivative, trans-3,5,4′-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafi sh through the downregulation of VEGFR2 and cell-cycle modulation. J. Cell Biochem. 109, 339-346.
4. Bastianetto, S. and Quirion, R. (2010) Heme oxygenase 1: another possible target to explain the neuroprotective action of resveratrol, a multifaceted nutrient-based molecule. Exp. Neurol. 225, 237-239.
5. Behl, C. (1998) Effects of glucocorticoids on oxidative stress-induced hippocampal cell death: implications for the pathogenesis of Alzheimer's disease. Exp. Gerontol. 33, 689-696.
6. Belleri, M., Ribatti, D., Nicoli, S., Cotelli, F., Forti, L., Vannini, V., Stivala, L. A. and Presta, M. (2005) Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4′-trimethoxystilbene. Mol. Pharmacol. 67, 1451-1459.
7. Borra, M. T., Smith, B. C. and Denu, J. M. (2005) Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 280, 17187-17195.
8. Chen, C. Y., Jang, J. H., Li, M. H. and Surh, Y. J. (2005) Resveratrol upregulates heme oxygenase-1 expression via activation of NFE2-related factor 2 in PC12 cells. Biochem. Biophys. Res. Commun. 331, 993-1000.
9. Chong, Z. Z., Shang, Y. C., Wang, S. and Maiese, K. (2012) SIRT1: new avenues of discovery for disorders of oxidative stress. Expert. Opin. Ther. Targets 16, 167-178.
10. Darvesh, A. S., Carroll, R. T., Bishayee, A., Geldenhuys, W. J. and Van der Schyf, C. J. (2010) Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev. Neurother. 10, 729-745.
11. Delmas, D., Solary, E. and Latruffe, N. (2011) Resveratrol, a phytochemical inducer of multiple cell death pathways: apoptosis, autophagy and mitotic catastrophe. Curr. Med. Chem. 18, 1100-1121.
12. Deng, Y. H., Alex, D., Huang, H. Q., Wang, N., Yu, N., Wang, Y. T., Leung, G. P. and Lee, S. M. (2011) Inhibition of TNF-α-mediated endothelial cell-monocyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3,5,4′-trimethoxystilbene. Phytother. Res. 25, 451-457.
13. Floyd, R. A. and Hensley, K. (2002) Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. ging 23, 795-807.
14. Fukui, M., Choi, H. J. and Zhu, B. T. (2010) Mechanism for the protective effect of resveratrol against oxidative stress-induced neuronal death. Free Radic. Biol. Med. 49, 800-813.
15. Hall, E. D., Vaishnav, R. A. and Mustafa, A. G. (2010) Antioxidant therapies for traumatic brain injury. Neurotherapeutics 7, 51-61.
16. Hasegawa, K., Wakino, S., Yoshioka, K., Tatematsu, S., Hara, Y., Minakuchi, H., Washida, N., Tokuyama, H., Hayashi, K. and Itoh, H. (2008) Sirt1 protects against oxidative stress-induced renal tubular cell apoptosis by the bidirectional regulation of catalase expression. Biochem. Biophys. Res. Commun. 372, 51-66.
17. Hasegawa, K. and Yoshikawa, K. (2008) Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J. Neurosci. 28, 8772-8784.
18. Hasiah, A. H., Ghazali, A. R., Weber, J. F., Velu, S., Thomas, N. F. and Inayat Hussain, S. H. (2011) Cytotoxic and antioxidant effects of methoxylated stilbene analogues on HepG2 hepatoma and Chang liver cells: Implications for structure activity relationship. Hum. Exp. Toxicol. 30, 138-144.
19. Ho, D. J., Calingasan, N. Y., Wille, E., Dumont, M. and Beal, M. F. (2010) Resveratrol protects against peripheral defi cits in a mouse model of Huntington's disease. Exp. Neurol. 225, 74-84.
20. Huang, X. and Zhu, H. L. (2011) Resveratrol and its analogues: promising antitumor agents. Anticancer Agents Med. Chem. 11, 479-490.
21. Jazwa, A. and Cuadrado, A. (2010) Targeting heme oxygenase-1 for neuroprotection and neuroinfl ammation in neurodegenerative diseases. Curr. Drug Targets 11, 1517-1531.
22. Jeong, G. S., An, R. B., Pae, H. O., Chung, H. T., Yoon, K. H., Kang, D. G., Lee, H. S. and Kim, Y. C. (2008) Cudratricusxanthone A protects mouse hippocampal cells against glutamate-induced neurotoxicity via the induction of heme oxygenase-1. Planta Med. 74, 1368-1373.
23. Kao, C. L., Chen, L. K., Chang, Y. L., Yung, M. C., Hsu, C. C., Chen, Y. C., Lo, W. L., Chen, S. J., Ku, H. H. and Hwang, S. J. (2010) Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. J. Atheroscler. Thromb. 17, 970-979.
24. Kelsey, N. A., Wilkins, H. M. and Linseman, D. A. (2010) Nutraceutical antioxidants as novel neuroprotective agents. Molecules 15, 7792-7814.
25. Kim, D., Nguyen, M. D., Dobbin, M. M., Fischer, A., Sananbenesi, F., Rodgers, J. T., Delalle, I., Baur, J. A., Sui, G., Armour, S. M., Puigserver, P., Sinclair, D. A. and Tsai, L. H. (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 26, 3169-3179.
26. Kulawiak, B. and Szewczyk, A. (2012) Glutamate-induced cell death in HT22 mouse hippocampal cells is attenuated by paxilline, a BK channel inhibitor. Mitochondrion. 12, 169-172.
27. Li, F., Gong, Q., Dong, H. and Shi, J. (2012) Resveratrol, a neuroprotective supplement for Alzheimer's disease. Curr. Pharm. Des. 18, 27-33.
28. Martin, S., Andriambeloson, E., Takeda, K. and Andriantsitohaina, R. (2002) Red wine polyphenols increase calcium in bovine aortic endothelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Br. J. Pharmacol. 135, 1579-1587.
29. Ndiaye, M., Chataigneau, M., Lobysheva, I., Chataigneau, T. and Schini-Kerth, V. B. (2005) Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redoxsensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. FASEB J. 19, 455-457.
30. Pae, H. O., Kim, E. C. and Chung, H. T. (2008) Integrative survival response evoked by heme oxygenase-1 and heme metabolites. J. Clin. Biochem. Nutr. 42, 197-203.
31. Pae, H. O., Son, Y., Kim, N. H., Jeong, H. J., Chang, K. C. and Chung, H. T. (2010) Role of heme oxygenase in preserving vascular bioactive NO. Nitric Oxide 23, 251-257.
32. Pan, M. H., Gao, J. H., Lai, C. S., Wang, Y. J., Chen, W. M., Lo, C. Y., Wang, M., Dushenkov, S. and Ho, C. T. (2008) Antitumor activity of 3,5,4′-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice. Mol. Carcinog. 47, 184-196.
33. Pocernich, C. B., Lange, M. L., Sultana, R. and Butterfield, D. A. (2011) Nutritional approaches to modulate oxidative stress in Alzheimer's disease. Curr. Alzheimer Res. 8, 452-469.
34. Ren, J., Fan, C., Chen, N., Huang, J. and Yang, Q. (2011) Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem. Res. 36, 2352-2362.
35. Richard, T., Pawlus, A. D., Iglésias, M. L., Pedrot, E., Waffo-Teguo, P., Mérillon, J. M. and Monti, J. P. (2011) Neuroprotective properties of resveratrol and derivatives. Ann. N. Y. Acad. Sci. 1215, 103-108.
36. Robb, E. L. and Stuart, J. A. (2010) trans-Resveratrol as a neuroprotectant. Molecules 15, 1196-1212.
37. Shindler, K. S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D. C. and Rostami, A. (2010) Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. J. Neuroophthalmol. 30, 328-339.
38. Son, Y., Lee, J. H., Kim, N. H., Surh, N. Y., Kim, E. C., Chung, H. T., Kang, D. G. and Pae, H. O. (2010) Dilinoleoylphosphatidylcholine induces the expression of the anti-infl ammatory heme oxygenase-1 in RAW264.7 macrophages. Biofactors 36, 210-215.
39. Srivastava, S. and Haigis, M. C. (2011) Role of sirtuins and calorie restriction in neuroprotection: implications in Alzheimer's and Parkinson's diseases. Curr. Pharm. Des. 17, 3418-3433.
40. Steele, M., Stuchbury, G. and Münch, G. (2007) The molecular basis of the prevention of Alzheimer's disease through healthy nutrition. Exp. Gerontol. 42, 28-36.
41. Sun, A. Y., Wang, Q., Simonyi, A. and Sun, G. Y. (2008) Botanical phenolics and brain health. Neuromolecular Med. 10, 259-274.
42. Sun, A. Y., Wang, Q., Simonyi, A. and Sun, G. Y. (2010) Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol. Neurobiol. 41, 375-383.
43. Wang, J., Zhang, Y., Tang, L., Zhang, N. and Fan, D. (2011a) Protective effects of resveratrol through the up-regulation of SIRT1 expression in the mutant hSOD1-G93A-bearing motor neuron-like cell culture model of amyotrophic lateral sclerosis. Neurosci. Lett. 503, 250-255.
44. Wang, R. H., Kim, H. S., Xiao, C., Xu, X., Gavrilova, O. and Deng, C. X. (2011b) Hepatic Sirt1 defi ciency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J. Clin. Invest. 121, 4477-4490.
45. Wu, M. L., Ho, Y. C. and Yet, S. F. (2011a) A central role of heme oxygenase-1 in cardiovascular protection. Antioxid. Redox. Signal. 15, 1835-1846.
46. Wu, Y., Li, X., Zhu, J. X., Xie, W., Le, W., Fan, Z., Jankovic, J. and Pan, T. (2011b) Resveratrol-activated AMPK/SIRT1/autophagy in cellular models of Parkinson's disease. Neurosignals. 19, 163-174.
47. Xia, L., Ding, F., Zhu, J. H. and Fu, G. S. (2011) Resveratrol attenuates apoptosis of pulmonary microvascular endothelial cells induced by high shear stress and proinfl ammatory factors. Hum. Cell 24, 127-133.
48. Yang, Y. T., Weng, C. J., Ho, C. T. and Yen, G. C. (2009) Resveratrol analog-3,5,4′-trimethoxy-trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression. Mol. Nutr. Food. Res. 53, 407-416.
49. Zhang, F., Wang, S., Gan, L., Vosler, P. S., Gao, Y., Zigmond, M. J. and Chen, J. (2011) Protective effects and mechanisms of sirtuins in the nervous system. Prog. Neurobiol. 95, 373-395